- Previous Close
71.250 - Open
70.100 - Bid 71.300 x --
- Ask 71.500 x --
- Day's Range
68.850 - 73.350 - 52 Week Range
35.000 - 75.200 - Volume
3,645,922 - Avg. Volume
3,577,979 - Market Cap (intraday)
73.009B - Beta (5Y Monthly) 0.79
- PE Ratio (TTM)
32.31 - EPS (TTM)
2.210 - Earnings Date --
- Forward Dividend & Yield 0.65 (0.91%)
- Ex-Dividend Date Jun 17, 2025
- 1y Target Est
79.74
Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People's Republic of China. It also manufactures rare ginsenosides technology-based functional foods; and offers medical devices. The company offers its functional skincare products, medical dressings, and functional foods primarily under the Comfy, Collgene, Keyu, and SKIGIN brands. Giant Biogene Holding Co., Ltd. was founded in 2000 and is headquartered in Xi'an, the People's Republic of China.
www.xajuzi.com1,758
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2367.HK
View MorePerformance Overview: 2367.HK
Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2367.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2367.HK
View MoreValuation Measures
Market Cap
72.86B
Enterprise Value
66.58B
Trailing P/E
32.27
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
12.02
Price/Book (mrq)
9.56
Enterprise Value/Revenue
11.22
Enterprise Value/EBITDA
25.27
Financial Highlights
Profitability and Income Statement
Profit Margin
37.23%
Return on Assets (ttm)
21.89%
Return on Equity (ttm)
35.88%
Revenue (ttm)
5.54B
Net Income Avi to Common (ttm)
2.06B
Diluted EPS (ttm)
2.210
Balance Sheet and Cash Flow
Total Cash (mrq)
5.88B
Total Debt/Equity (mrq)
0.09%
Levered Free Cash Flow (ttm)
--